The World Health Organization expects to receive 2 billion doses of COVID-19 vaccines under the COVAX program in 2021.

Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.

Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.

The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.

A new class of drugs such as HIF-2α inhibitors is considered as an addition to standard cancer immunotherapy.

Chinese scientists are actively engaged in the development of improved immunomodulators.

Studies have shown that, on average, people eat about 5 grams of plastic every week.

A new control dyslipidemia method has been proposed instead of appropriate statins and lipid-lowering drugs.

Chinese scientists have developed a unique vaccine that is safe and has low adverse reactions.

Scientists have found a way to "recharge" and increase the brain’s performance.